×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
LON:EVG

Evgen Pharma Share Forecast, Price & News

GBX 3.45
0.00 (0.00%)
(As of 07/4/2022 12:00 AM ET)
Add
Compare
Today's Range
3.45
3.49
50-Day Range
3.42
4.19
52-Week Range
3
9
Volume
N/A
Average Volume
353,586 shs
Market Capitalization
£9.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Evgen Pharma MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.22 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive EVG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evgen Pharma and its competitors with MarketBeat's FREE daily newsletter.

Evgen Pharma logo

About Evgen Pharma (LON:EVG) Stock

Evgen Pharma plc, a clinical stage drug development company, focuses in the development of sulforaphane-based compunds for the treatment of multiple diseases. Its core technology is Sulforadex, a means of synthesizing and stabilizing the naturally occurring compound sulforaphane. The company's lead product is SFX-01, a synthetic and stabilized form of sulforaphane that is in Phase II clinical trials for the treatment of metastatic breast cancer; in preclinical stage for glioma and glioblastoma; and in Phase IIb for treating acute respiratory infections. Evgen Pharma plc was founded in 2007 and is headquartered in Nether Alderley, the United Kingdom.

EVG Stock News Headlines

Evgen Pharma Drops on FY 2022 Pretax Loss
Evgen Pharma launches new collaboration for lead asset
Ebiquity returns to profit in the first half of 2021
Evgen Pharma PLC
Evgen Pharma PLC : Appointment of Chief Business Officer
SMALL CAP SHARE IDEAS: Evgen Pharma
Evgen Pharma PLC : Holding(s) in Company
Evgen Pharma PLC : Posting of Circular & Notice of GM
See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
8
Year Founded
N/A

Company Calendar

Last Earnings
6/15/2020
Today
7/04/2022

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 3.30 per share
Book Value
GBX 3.40 per share

Miscellaneous

Free Float
N/A
Market Cap
£9.48 million
Optionable
Not Optionable
Beta
N/A














Evgen Pharma Frequently Asked Questions

How has Evgen Pharma's stock price performed in 2022?

Evgen Pharma's stock was trading at GBX 5.15 on January 1st, 2022. Since then, EVG shares have decreased by 33.0% and is now trading at GBX 3.45.
View the best growth stocks for 2022 here
.

How were Evgen Pharma's earnings last quarter?

Evgen Pharma plc (LON:EVG) posted its quarterly earnings results on Monday, June, 15th. The company reported ($2.10) earnings per share for the quarter, hitting the consensus estimate of ($2.10).
View Evgen Pharma's earnings history
.

Who are Evgen Pharma's key executives?

Evgen Pharma's management team includes the following people:
  • Dr. Huw Jones BSc, Ph.D., CEO & Exec. Director (Age 62, Pay $224.4k)
  • Mr. Richard Anthony Moulson, CFO & Exec. Director (Age 60, Pay $107.28k)
  • Dr. Helen Kuhlman, Chief Bus. Officer
  • Dr. Glen Clack FFPM, M.D., Chief Medical Officer
  • Ms. Liz Jenkins, Regulatory Consultant
  • Prof. Albena Dinkova-Kostova, Independent Scientific Advisor
  • Prof. Giovanni Mann, Independent Scientific Advisor

What is Evgen Pharma's stock symbol?

Evgen Pharma trades on the London Stock Exchange (LON) under the ticker symbol "EVG."

How do I buy shares of Evgen Pharma?

Shares of EVG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Evgen Pharma's stock price today?

One share of EVG stock can currently be purchased for approximately GBX 3.45.

How much money does Evgen Pharma make?

Evgen Pharma (LON:EVG) has a market capitalization of £9.48 million.

How many employees does Evgen Pharma have?

Evgen Pharma employs 8 workers across the globe.

How can I contact Evgen Pharma?

Evgen Pharma's mailing address is The Colony 146 Brownlow Hill, Altrincham Road, WILMSLOW, SK9 4LY, United Kingdom. The official website for Evgen Pharma is evgen.com. The company can be reached via phone at +44-151-7053532.

This page (LON:EVG) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.